Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-011598
Filing Date
2025-08-05
Accepted
2025-08-05 09:00:44
Documents
55
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1415332
2 EX-31.1 ex31-1.htm EX-31.1 20057
3 EX-31.2 ex31-2.htm EX-31.2 20074
4 EX-32.1 ex32-1.htm EX-32.1 8292
  Complete submission text file 0001493152-25-011598.txt   5267285

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE imnn-20250630.xsd EX-101.SCH 34941
6 XBRL CALCULATION FILE imnn-20250630_cal.xml EX-101.CAL 39110
7 XBRL DEFINITION FILE imnn-20250630_def.xml EX-101.DEF 121372
8 XBRL LABEL FILE imnn-20250630_lab.xml EX-101.LAB 336326
9 XBRL PRESENTATION FILE imnn-20250630_pre.xml EX-101.PRE 245245
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 755781
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 251183131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)